Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Once-Daily Oral Dose of BeneFlax to Healthy Older Adults

Authors not listed

University of Saskatchewan · 2013

Abstract

The investigators are investigating whether the flax lignan, secoisolariciresinol diglucoside, decreases oxidative stress and inflammation. The flax seed lignan is believed to be broken down in the body to produce the health benefits of flax. Flax lignan is separated from the whole flax seed as this compound is believed to have health effects. Decreasing oxidative stress and inflammation should improve a number of the problems associated with aging. This intervention consists of 600 milligrams of the flax lignan SDG daily or an equivalent amount of whey protein. The investigators are comparing lignan to a placebo (whey powder) to examine whether a dietary intervention (i.e. flax seed containing lignan) might decrease oxidative stress and inflammation.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Anonymous. (2013). Once-Daily Oral Dose of BeneFlax to Healthy Older Adults. <em>University of Saskatchewan</em>. https://clinicaltrials.gov/study/NCT01846117
Vancouver
Anonymous. Once-Daily Oral Dose of BeneFlax to Healthy Older Adults. University of Saskatchewan. 2013.
BibTeX
@misc{anon2013OnceDa, title = {Once-Daily Oral Dose of BeneFlax to Healthy Older Adults}, author = {Anonymous}, journal = {University of Saskatchewan}, year = {2013}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings